Christian Angermayer (#3030)
- $ 1 B
- Investments
- Germany
- M
- 48 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Christian Angermayer invests in life sciences, fintech, AI, psychedelics and cryptocurrencies through his family office Apeiron Investment Group. He made his first millions cofounding biotech firm Ribopharma with his college professors; he sold his stake when it merged with Alnylam in 2003. His Malta-based Apeiron owns shares in several publicly traded firms and private companies in the U.S., Germany, Canada and Australia. His holdings include psychedelics biopharma firm Atai Life Sciences and blockchain holding company Samara, alongside co-investor Mike Novogratz. He owns an extensive art collection that includes ancient artifacts highlighting the role that psychedelics have played in human history.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Christian Angermayer’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Christian Angermayer’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.2B
(May 4, 2026)
© Iconic Billionaires